Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biojector 2000 Open-Label Safety Study (BOSS) to Evaluate Signs and Symptoms Associated With a Needle-free Injection Device for Administration of Fuzeon to Patients With HIV-1 Infection

NCT00337701 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00337701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00337701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biojector 2000 Open-Label Safety Study (BOSS) to Evaluate Signs and Symptoms Associated With a Needle-free Injection Device for Administration of Fuzeon to Patients With HIV-1 Infection
Lead sponsor
Hoffmann-La Roche
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2006
Completion date
January 31, 2007
Enrollment
326 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections